Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-based payments (Tables)

v3.22.1
Share-based payments (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payments  
Schedule of stock options activity

    Number of
share options
   

Weighted

average
exercise price

£

 
             
Outstanding at January 1, 2021     5,329,230       0.46  
Granted during the period     -       -  
Exercised during the period     -       -  
Forfeited during the period     -       -  
Outstanding at December 31, 2021     5,329,230       0.46  
                 
Exercisable at December 31, 2021     5,329,230       0.46  
Not exercisable at December 31, 2021     -       -  

 

No options were granted or exercised in the period to December 31 2021.

 

    Number of
share options
   

Weighted

average
exercise price

 
          £  
             
Outstanding at January 1, 2020     4,966,740       0.42  
Granted during the period     465,490       1.08  
Exercised during the period     -       -  
Forfeited during the period     (103,000 )     1.31  
Outstanding at December 31, 2020     5,329,230       0.46  
                 
Exercisable at December 31, 2020     5,329,230       0.46  
Not exercisable at December 31, 2020     -       -  

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

 

19. Share-based payments (continued)

 

    Number of
share options
   

Weighted

average
exercise price

 
          £  
             
Outstanding at January 1, 2019     4,221,050       0.10  
Granted during the period     823,190       2.07  
Exercised during the period     -       -  
Forfeited during the period     (77,500 )     0.60  
Outstanding at December 31, 2019     4,966,740       0.42  
                 
Exercisable at December 31, 2019     4,492,740       0.32  
Not exercisable at December 31, 2019     474,000       1.34  
Schedule of share-based model inputs

 

          2020     2019  

The model inputs were as follows:

                 
          2020     2019  
Weighted average share price           £ 2.16       3.85  
Expected volatility             75 %     70 %
Risk free interest rate             0.01 %     0.50 %
Expected option life             1 year       2 years  
Dividend yield     %       0.0 %     0.0 %
 

The model inputs were as follows:

 

    2020  
Weighted average share price     4.16  
Expected volatility     70 %
Risk free interest rate     0.30 %
Expected option life     1.33 years  
Dividend yield     0.0 %